» Articles » PMID: 17707342

Mixed Lineage Kinase 3 Connects Reactive Oxygen Species to C-Jun NH2-terminal Kinase-induced Mitochondrial Apoptosis in Genipin-treated PC3 Human Prostate Cancer Cells

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2007 Aug 21
PMID 17707342
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

It has been reported that genipin, the aglycone of geniposide, induces apoptotic cell death in human hepatoma cells via a NADPH oxidase-reactive oxygen species (ROS)-c-Jun NH(2)-terminal kinase (JNK)-dependent activation of mitochondrial pathway. This continuing work aimed to define that mixed lineage kinase 3 (MLK3) is a key mediator, which connect between ROS and JNK in genipin-induced cell death signaling. In PC3 human prostate cancer cells, genipin stimulated MLK3 activity in concentration- and time-dependent manner. The PC3 cells stably transfected with dominant-negative form of MLK3 was less susceptible to population of the sub-G1 apoptotic cells, activation of caspase, collapse of mitochondrial membrane potential, and release of cytochrome c triggered by genipin, suggesting a crucial role of MLK3 in genipin signaling to apoptotic cell death. Diphenyleneiodonium (DPI), a specific inhibitor of NADPH oxidase, markedly inhibited ROS generation and MLK3 phosphorylation in the genipin-treated cells. Pretreatment with SP0600125, a specific inhibitor of JNK but neither U0126, a specific inhibitor of MEK1/2 nor PD169316, a specific inhibitor of p38 suppressed genipin-induced apoptotic cell death. Notably, both the phosphorylation of JNK and induction of c-Jun induced by genipin were markedly inhibited in PC3-EGFP-MLK3 (K144R) cells expressing a dominant-negative MLK3 mutant. Taken together, our observations suggest genipin signaling to apoptosis of PC3 cells is mediated via activation of ROS-dependent MLK3, which leads to downstream activation of JNK.

Citing Articles

Genipin's potential as an anti-cancer agent: from phytochemical origins to clinical prospects.

Natallia L, Dama A, Gorica E, Darya K, Pena-Corona S, Cortes H Med Oncol. 2024; 41(8):186.

PMID: 38918260 DOI: 10.1007/s12032-024-02429-y.


Genipin, an Inhibitor of UCP2 as a Promising New Anticancer Agent: A Review of the Literature.

Cho Y Int J Mol Sci. 2022; 23(10).

PMID: 35628447 PMC: 9147402. DOI: 10.3390/ijms23105637.


Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer.

Miller K, Asim M Cells. 2022; 11(6).

PMID: 35326402 PMC: 8946764. DOI: 10.3390/cells11060952.


Three-Dimensional Printability of an ECM-Based Gelatin Methacryloyl (GelMA) Biomaterial for Potential Neuroregeneration.

Da Silva K, Kumar P, van Vuuren S, Pillay V, Choonara Y ACS Omega. 2021; 6(33):21368-21383.

PMID: 34471741 PMC: 8388000. DOI: 10.1021/acsomega.1c01903.


The regulatory function of mixed lineage kinase 3 in tumor and host immunity.

Kumar S, Singh S, Rana B, Rana A Pharmacol Ther. 2020; 219:107704.

PMID: 33045253 PMC: 7887016. DOI: 10.1016/j.pharmthera.2020.107704.